- About Us
- Services & Solutions
- Nucleic Acid Vaccines
- Viral Vector Vaccines
Offering End-to-End Solutions
As a leading Contract Development and Manufacturing Organization (CDMO), we support cGMP manufacturing of both bulk and final vaccine product to effectively meet your preclinical, clinical and commercial supply needs in a cost-effective manner.
The large-scale microbial-based facility utilized for vaccine lyophilization is designed and constructed based on U.S., EU and China cGMP standards. The site utilizes the same comprehensive quality systems implemented by all of our global GMP facilities. Site details include:
At the same location as the bulk vaccine is produced (for microbial-derived vaccines), WuXi Vaccines provides the full scope of final vaccine drug product manufacturing and fill services. Services include process development, tech transfer, facility fit, and robustness evaluation of final product manufacturing processes.
Highly flexible and automated final product GMP manufacturing
Fully-automated, robotic, gloveless, isolator-based Vanrx aseptic drug product fill system
In addition this site, fill of vaccines produced via microbial fermentation can also be performed at other manufacturing facilities globally, including lyophilized dosage forms.
Our dedicated team of highly-trained and experienced professionals allows us to offer: